CN1057096C - 蛋白质pl40多肽及编码该多肽的DNA - Google Patents

蛋白质pl40多肽及编码该多肽的DNA Download PDF

Info

Publication number
CN1057096C
CN1057096C CN94119935A CN94119935A CN1057096C CN 1057096 C CN1057096 C CN 1057096C CN 94119935 A CN94119935 A CN 94119935A CN 94119935 A CN94119935 A CN 94119935A CN 1057096 C CN1057096 C CN 1057096C
Authority
CN
China
Prior art keywords
val
ala
ser
leu
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94119935A
Other languages
English (en)
Chinese (zh)
Other versions
CN1112127A (zh
Inventor
田岛久男
北川幸一郎
大野博之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of CN1112127A publication Critical patent/CN1112127A/zh
Application granted granted Critical
Publication of CN1057096C publication Critical patent/CN1057096C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN94119935A 1993-11-24 1994-11-24 蛋白质pl40多肽及编码该多肽的DNA Expired - Fee Related CN1057096C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP315806/93 1993-11-24
JP315806/1993 1993-11-24
JP31580693 1993-11-24

Publications (2)

Publication Number Publication Date
CN1112127A CN1112127A (zh) 1995-11-22
CN1057096C true CN1057096C (zh) 2000-10-04

Family

ID=18069786

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94119935A Expired - Fee Related CN1057096C (zh) 1993-11-24 1994-11-24 蛋白质pl40多肽及编码该多肽的DNA

Country Status (11)

Country Link
US (5) US5506205A (enExample)
EP (1) EP0659883B1 (enExample)
KR (1) KR100256664B1 (enExample)
CN (1) CN1057096C (enExample)
AT (1) ATE237683T1 (enExample)
CA (1) CA2136565C (enExample)
DE (1) DE69432511T2 (enExample)
DK (1) DK0659883T3 (enExample)
ES (1) ES2196016T3 (enExample)
PT (1) PT659883E (enExample)
TW (1) TW311913B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506205A (en) 1993-11-24 1996-04-09 Ono Pharmaceutical Co., Ltd. Polypeptide of protein p140 and DNAs encoding it
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
GB0208089D0 (en) 2002-04-09 2002-05-22 Oxford Glycosciences Uk Ltd Protein
EP2046313A4 (en) * 2006-07-10 2012-01-25 Glucox Biotech Ab USE OF NAPHTHOCHINONES IN THE TREATMENT AND CONTROL OF DIABETES, INSULIN RESISTANCE AND HYPERGLYCEMIA
EP2517725A1 (en) * 2007-05-01 2012-10-31 Board Of Regents, The University Of Texas Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
CN105085630A (zh) * 2015-08-31 2015-11-25 苏州普罗达生物科技有限公司 mTOR抑制多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260200A (en) * 1991-01-18 1993-11-09 Joslin Diabetes Center, Inc. Isolated DNA encoding an insulin receptor substrate
US5811396A (en) * 1991-03-14 1998-09-22 The United States Of America As Represented By The Department Of Health And Human Services TRK tyrosine kinase receptor is the physiological receptor for nerve growth factor
US5506205A (en) * 1993-11-24 1996-04-09 Ono Pharmaceutical Co., Ltd. Polypeptide of protein p140 and DNAs encoding it

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ONCOGENE,8(10) 1993.10.1 Bohme等"PCR mediated detection of a new human receptor-tyrosine-RINASE,hek 2.";ONCOGENE,8(7) 1993.7.1 Sajiadi FG等"Five novel avian Eph-relatedtyro-sine kinases are differentia lly rxpressed *
ONCOGENE,8(10) 1993.10.1 Bohme等"PCR mediated detection of a new human receptor-tyrosine-RINASE,hek 2." *
ONCOGENE,8(7) 1993.7.1 Sajiadi FG等"Five novel avian Eph-relatedtyro-sine kinases are differentia lly rxpressed *

Also Published As

Publication number Publication date
US5506205A (en) 1996-04-09
DK0659883T3 (da) 2003-08-04
ATE237683T1 (de) 2003-05-15
KR950014135A (ko) 1995-06-15
CN1112127A (zh) 1995-11-22
DE69432511T2 (de) 2004-04-29
KR100256664B1 (ko) 2000-05-15
PT659883E (pt) 2003-07-31
CA2136565C (en) 1999-11-09
DE69432511D1 (de) 2003-05-22
US5804411A (en) 1998-09-08
EP0659883B1 (en) 2003-04-16
US6432913B1 (en) 2002-08-13
CA2136565A1 (en) 1995-05-25
EP0659883A2 (en) 1995-06-28
ES2196016T3 (es) 2003-12-16
US20030170865A1 (en) 2003-09-11
US6303320B1 (en) 2001-10-16
TW311913B (enExample) 1997-08-01
EP0659883A3 (en) 1997-06-25

Similar Documents

Publication Publication Date Title
CN1057096C (zh) 蛋白质pl40多肽及编码该多肽的DNA
CN1283793C (zh) 具有骨骼肌刺激活性和免疫调节作用的趋化素样因子超家族
CN1169954C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1234728C (zh) 新的人淋巴因子、其编码序列及用途
CN1277844C (zh) 新型人细胞周期蛋白,其编码序列及用途
CN1241941C (zh) 一种促进神经分化和抗细胞凋亡的蛋白质及其编码基因
CN1704426A (zh) 一种癌症基因及其医药用途
CN1290861C (zh) 新型人骨髓基质细胞来源的1型磷酸酶抑制因子,其编码序列及用途
CN1273485C (zh) 新型人树突状细胞来源的免疫球蛋白样受体,其编码序列及用途
CN1277995A (zh) 一种新的多肽——人细胞色素氧化酶相关蛋白37和编码这种多肽的多核苷酸
CN1151251C (zh) 新的人一磷酸鸟苷还原酶、其编码序列及用途
CN1231497C (zh) 具有促进小鼠nih/3t3细胞转化功能的新的人蛋白及其编码序列
CN1296973A (zh) 一种新的多肽——人钙结合蛋白42号和编码这种多肽的多核苷酸
CN1298005A (zh) 一种新的多肽——人唾液酸转移酶27和编码这种多肽的多核苷酸
CN1493583A (zh) 一种新的多肽-人糖蛋白42和编码这种多肽的多核苷酸
CN1923276A (zh) NFκB信号通路的重要调控蛋白PAK7
CN1464052A (zh) 一种新的多肽--人rna解螺旋酶95和编码这种多肽的多核苷酸
CN1517362A (zh) 一种新的多肽——人含atp/gtp结合结构域的核糖体蛋白s9和编码这种多肽的多核苷酸
CN1618805A (zh) 神经系统发育相关蛋白及其编码序列和用途
CN1328026A (zh) 一种新的多肽——人基因多效调节物1(plrg1)蛋白9.9和编码这种多肽的多核苷酸
CN1345741A (zh) 一种新的多肽——ef-手型钙结合蛋白9.24和编码这种多肽的多核苷酸
CN1534043A (zh) 人骨髓基质细胞来源的泛素样分子及其编码序列和用途
CN1493586A (zh) 一种多肽-人转录调控蛋白38和编码这种多肽的多核苷酸
CN1493590A (zh) 一种多肽-人细胞分裂调节蛋白27和编码这种多肽的多核苷酸
CN1345756A (zh) 一种新的多肽——同边缘系统相联系的膜蛋白(lamp)36.85和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee